Upgrade to SI Premium - Free Trial

Wolfe Research Upgrades Edwards Lifesciences (EW) to Outperform

April 1, 2026 5:33 AM
Wolfe Research analyst Mike Polark upgraded Edwards Lifesciences (NYSE: EW) from Peerperform to Outperform with a price target of $92.00.The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Hot Upgrades Upgrades